You have 3 free articles left this month. Get your free Basic subscription now and gain instant access to more.

Bulgaria's Sopharma sales up 44% y/y in April as exports recover

Bulgaria's Sopharma sales up 44% y/y in April as exports recover Photo: Sopharma / All rights reserved.

Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Thursday that its sales revenue rose 44% year-on-year in April on the back of a surge in domestic sales as well as an improvement in major markets overseas.

Domestic sales were 60% higher last month than in April 2021, Sopharma said in a stock exchange filing.

Export sales increased by 38% in annual terms due to "an erratic recovery of activity in major foreign markets," after a slump in March resulting from the war in Ukraine.

Sopharma's total sales revenue for the first four months of 2022 grew by 34% year-on-year. Both domestic and export sales increased in the January-April period, by 75% and 10% respectively.

Shares in Sopharma inched down 0.45% to 4.38 levs ($2.36/ 2.23euro) as at 1405 CEST on the stock exchange in Sofia.

(1 euro = 1.95583 levs)

Share this story
SeeNews in Brief

View our Newsletters

 
Compare